CAR-engineered cell therapies: current understandings and future perspectives
Abstract Chimeric antigen receptor (CAR)–engineered cell therapies represent a significant breakthrough in immunotherapy, initially in cancer and now expanding into diverse clinical fields. While originally developed for oncology, these platforms are increasingly being adapted for non-malignant cond...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2026-01-01
|
| Serie: | Molecular Biomedicine |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s43556-025-00401-4 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|